When energy, knowledge and skills of a motivated group of people is combined, a team can accomplish more then you can think of.
Motivation is a key player in success as it increases teamwork and stimulates dedicated problem solving. Successful delegation by a team leader is important for the team spirit as well. Delegation engages the team by taking more responsibility and increases the drive to aim for the best results.
It sounds easy, just motivate and delegate your team or just be motivated to the goals you want to achieve. But it is not that simple. Especially in the current situation where working from home became the standard.
But how to successfully motivate, but also delegate your team (when it is not possible to see them face-to-face)?
And how to stay motivated when distractions are just around the corner? And when work-life boundaries are fading away?
Alex Cloherty, Junior TOPX Ambassador wrote a recap article about this event on how to Motivate and Delegate in your team. Read the full article here
TOPX Online Event | Motivate & Delegate | 25 January | 15.00 – 17.30
15:15 – 15:25 Official opening by Haifen Hu (Hyphen Projects) & Katka Franke (Frame Therapeutics)
15:25 – 15:45 Interview - Janneke Meulenberg (MeiraGTx)
15:45 – 16:05 Interview - Christel Menet (Confo Therapeutics)
16:05 – 16:25 Presentation - Annemie Webers (Career & Live)
16:25 – 16:45 Interactive break-outs with all speakers and attendees
16:45 – 17:00 Recap with all speakers
17:00 – 17:30 Network carrousel
CEO and founder, Career & Live
Annemie Webers, CEO and founder of Career & Live. We strongly believe that organizations and people perform better, cooperate more and are more creative when the workload and work stress is within limits. Work life balance is key for a healthy working environment, specially nowadays because working hybrid is the standard. Our approach is science- and evidenced based, always inspiring and with al little bit of humor.Every body should have the opportunity to have an engaged life, one life, just live it.
Annemie is an professional trainer, team(coach), work designer and key note speaker specialized in work life balance, stress and engagement.
Christel Menet
CSO, Confo Therapeutics
Christel Menet (ir.Ph.D.) joined Confo Therapeutics in May 2016 from Galapagos NV where she was Director of Medicinal Chemistry. After a PhD in organic chemistry at University of Manchester in Professor Clayden’s lab, she started her professional career as a medicinal chemist at Evotec in 2002. She then joined Faust Pharmaceuticals in 2004, today called Domain therapeutics, a biotech company specialized in GPCR drug discovery. Christel was one of the first chemists at Galapagos NV in 2005, where, under her leadership, filgotinib was discovered and moved forward to pre-clinical development (today in Phase 3 in rheumatoid arthritis). She also played a key role in a number of projects and advanced several compounds into preclinical phase. She is inventor on more than 20 patent applications and brings over 14 years of research and development experience in drug discovery to Confo Therapeutics.
Janneke Meulenberg
Managing Director, MeiraGTx
Janneke Meulenberg has over 25 years of experience in the Biopharmaceutical industry. She graduated cum laude from the University of Groningen, received a PhD in Biochemistry from the University of Amsterdam and holds an MBA from RSM Erasmus University. Janneke Meulenberg started her career in industry at ID-Lelystad, where she headed a world leading R&D team developing veterinary vaccines in collaboration with Boehringer Ingelheim. She joined the management team of Amsterdam Molecular Therapeutics (now UniQure) in 2000, where she was responsible for developing Glybera® from research to registration studies. Glybera® is the first gene therapy that has received market approval in the Western World. Between 2008 and 2015, Janneke Meulenberg was CEO of ORCA Therapeutics B.V., a biopharmaceutical company developing innovative oncolytic adenoviruses and between 2015 and 2019 she was CEO of ViciniVax, a company developing immunotherapeutic cancer vaccines. In 2015, Janneke Meulenberg was appointed COO of gene therapy company Arthrogen BV. After the acquisition of Arthrogen in 2019, she became Managing Director of MeiraGTx Netherlands B.V. She is author of numerous peer-reviewed publications, book chapters, and inventor on several patents.
Katka Franke
Principal Scientist
Immunology, Frame Therapeutics
I graduated from Pharmaceutical Sciences (PharmD) followed by PhD in Pharmacology, both obtained in my land of origin, Slovakia. In 2009, I moved to the Netherlands where I obtained my second PhD in Immunology from Vrije Universiteit in Amsterdam. This was followed by several years of academic research performed at Sanquin Research in the field of immuno-oncology, combined with projects performed in collaboration with industrial partners. The experience from working with industry motivated my transition from academia, with my first position being a consultant for oncology drug development at CATO SMS. Currently, in my role as Principal Scientist at Frame Therapeutics I am responsible for preclinical and clinical development of various cancer immunotherapy programs.
You can sign up for this online event here or by clicking on the register button below. After registration, you will receive a confirmation email. Closer to the event, instructions on how to attend the virtual event will follow.
TOPX members can join this online meeting for free. Register here as member. You will then receive an e-mail with practical details a few days before the online event.
Are you not a member? Then you can buy a ticket for €100 (excl. VAT).
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects